Jeanne Mendell

Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation

Stuart J. Connolly, Indravadan Patel, Daniel E. Salazar et al. · Thrombosis and Haemostasis · 2010 · 343 citations

Medicine, Pharmacology, Pharmacotherapy +12

Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor

Jeanne Mendell, Hamim Zahir, Nobuko Matsushima et al. · American Journal of Cardiovascular Drugs · 2013 · 223 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetics, Biotransformation, and Mass Balance of Edoxaban, a Selective, Direct Factor Xa Inhibitor, in Humans

Mohinder S. Bathala, Hiroshi Masumoto, Toshihiro Oguma et al. · Drug Metabolism and Disposition · 2012 · 190 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Bioavailability and Safety of the Factor Xa Inhibitor Edoxaban and the Effects of Quinidine in Healthy Subjects

Nobuko Matsushima, Frank Lee, Toshiyuki Sato et al. · Clinical Pharmacology in Drug Development · 2013 · 152 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation

Jeanne Mendell, Helen Kastrissios, Michelle Green et al. · Thrombosis and Haemostasis · 2012 · 150 citations

Pharmacy, Pharmacokinetics, Pharmacology +17